At Broadstreet we deliver solutions not formulas.
An open-minded and client-focused approach means our customized design process delivers the solution you need.
Broadstreet is a boutique technology solutions company for the health economics and outcomes research community. We were founded on the idea that good research begins with a solid client-consultant relationship. We consistently deliver high-quality technology solutions for two key reasons.
We only take on work we know we’re great at and, more importantly, we put the client at the center of the process.
Epidemiology & Observational Studies
Our team designs and conducts observational studies used to characterize the clinical landscape and burden of disease for a product’s indication; estimate treatment effectiveness or safety; or parameterize economic models.
We provide rigorously conducted literature reviews following best practices guidelines, coupled with robust quantitative or qualitative evidence syntheses, to address a variety of research questions.
Our team develops HEOR models for a variety of contexts and settings. Our approach to model development and adaptation is to work with clients to design a customized structure and interface, in accordance with submission requirements and guidelines for best practice.
HEOR Technology Services
We have the IT capability to undertake big solutions. We create a variety of high-quality, custom digital products for our clients. These include tools that ensure for timely and accurate data collection, digital models that facilitate data analysis, and novel tools for dissemination of study findings.
Because we are epidemiologists, we often have people asking us questions about COVID-19 in general and about the vaccines in […]
Broadstreet HEOR and Sprout Health Solutions publish new research that reinforces complex treatment burden for hemophilia A
VANCOUVER, BC, July 20 – Broadstreet Health Economics & Outcomes Research (HEOR), with Sprout Health Solutions, announced the publication of […]
We are thrilled to be working with amazing collaborators to help understand the burden of Duchenne muscular dystrophy (DMD). Here […]